136 related articles for article (PubMed ID: 7529827)
21. The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells.
Assmann V; Marshall JF; Fieber C; Hofmann M; Hart IR
J Cell Sci; 1998 Jun; 111 ( Pt 12)():1685-94. PubMed ID: 9601098
[TBL] [Abstract][Full Text] [Related]
22. Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM.
Yang B; Zhang L; Turley EA
J Biol Chem; 1993 Apr; 268(12):8617-23. PubMed ID: 7682552
[TBL] [Abstract][Full Text] [Related]
23. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
Matou-Nasri S; Gaffney J; Kumar S; Slevin M
Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
[TBL] [Abstract][Full Text] [Related]
24. Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells.
Pilarski LM; Miszta H; Turley EA
J Immunol; 1993 May; 150(10):4292-302. PubMed ID: 7683315
[TBL] [Abstract][Full Text] [Related]
25. Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury.
Zaman A; Cui Z; Foley JP; Zhao H; Grimm PC; Delisser HM; Savani RC
Am J Respir Cell Mol Biol; 2005 Nov; 33(5):447-54. PubMed ID: 16037485
[TBL] [Abstract][Full Text] [Related]
26. The receptor for hyaluronan-mediated motility (RHAMM) expression in neonatal bronchiolar epithelium correlates negatively with lung air content.
Markasz L; Savani RC; Sedin G; Sindelar R
Early Hum Dev; 2018 Dec; 127():58-68. PubMed ID: 30312861
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronic Acid (HA) Receptors and the Motility of Schwann Cell(-Like) Phenotypes.
Ouasti S; Faroni A; Kingham PJ; Ghibaudi M; Reid AJ; Tirelli N
Cells; 2020 Jun; 9(6):. PubMed ID: 32560323
[TBL] [Abstract][Full Text] [Related]
28. Sequence, protein expression and extracellular-regulated kinase association of the hyaladherin RHAMM (receptor for hyaluronan mediated motility) in PC12 cells.
Lynn BD; Li X; Cattini PA; Nagy JI
Neurosci Lett; 2001 Jun; 306(1-2):49-52. PubMed ID: 11403955
[TBL] [Abstract][Full Text] [Related]
29. RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growth.
Berdiaki A; Thrapsanioti LN; Giatagana EM; K Karamanos N; C Savani R; N Tzanakakis G; Nikitovic D
Mol Biol Rep; 2023 Nov; 50(11):8937-8947. PubMed ID: 37710072
[TBL] [Abstract][Full Text] [Related]
30. During human thymic development, beta 1 integrins regulate adhesion, motility, and the outcome of RHAMM/hyaluronan engagement.
Gares SL; Giannakopoulos N; MacNeil D; Faull RJ; Pilarski LM
J Leukoc Biol; 1998 Dec; 64(6):781-90. PubMed ID: 9850161
[TBL] [Abstract][Full Text] [Related]
31. Identification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM/HMMR).
Esguerra KV; Tolg C; Akentieva N; Price M; Cho CF; Lewis JD; McCarthy JB; Turley EA; Luyt LG
Integr Biol (Camb); 2015 Dec; 7(12):1547-60. PubMed ID: 26456171
[TBL] [Abstract][Full Text] [Related]
32. A new polyclonal antibody that recognizes a human receptor for hyaluronan mediated motility.
Kuwabara H; Yoneda M; Nagai M; Hayasaki H; Mori H
Cancer Lett; 2004 Jul; 210(1):73-80. PubMed ID: 15172123
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms involved in suppression of NGF-induced neuronal differentiation of PC12 cells by hyaluronic acid.
Washio A; Kitamura C; Jimi E; Terashita M; Nishihara T
Exp Cell Res; 2009 Oct; 315(17):3036-43. PubMed ID: 19615362
[TBL] [Abstract][Full Text] [Related]
34. Expression and effects of hyaluronan and of the hyaluronan-binding protein hyaluronectin in newborn rat brain glial cell cultures.
Marret S; Delpech B; Delpech A; Asou H; Girard N; Courel MN; Chauzy C; Maingonnat C; Fessard C
J Neurochem; 1994 Apr; 62(4):1285-95. PubMed ID: 7510775
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronan and cell locomotion.
Turley EA
Cancer Metastasis Rev; 1992 Mar; 11(1):21-30. PubMed ID: 1380898
[TBL] [Abstract][Full Text] [Related]
36. Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis.
Bahrami SB; Tolg C; Peart T; Symonette C; Veiseh M; Umoh JU; Holdsworth DW; McCarthy JB; Luyt LG; Bissell MJ; Yazdani A; Turley EA
Integr Biol (Camb); 2017 Mar; 9(3):223-237. PubMed ID: 28217782
[TBL] [Abstract][Full Text] [Related]
37. Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis.
Minato A; Kudo Y; Noguchi H; Kohi S; Hasegawa Y; Sato N; Hirata K; Fujimoto N
Cancer Genomics Proteomics; 2023; 20(2):203-210. PubMed ID: 36870687
[TBL] [Abstract][Full Text] [Related]
38. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronan: RHAMM mediated cell locomotion and signaling in tumorigenesis.
Hall CL; Turley EA
J Neurooncol; 1995 Dec; 26(3):221-9. PubMed ID: 8750188
[TBL] [Abstract][Full Text] [Related]
40. CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).
Oldenburg D; Ru Y; Weinhaus B; Cash S; Theodorescu D; Guin S
BMC Cancer; 2016 Sep; 16(1):713. PubMed ID: 27595989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
